491 related articles for article (PubMed ID: 20175768)
1. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.
Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
3. Development of type I gastric carcinoid in patients with chronic atrophic gastritis.
Vannella L; Sbrozzi-Vanni A; Lahner E; Bordi C; Pilozzi E; Corleto VD; Osborn JF; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2011 Jun; 33(12):1361-9. PubMed ID: 21492197
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
5. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk.
Testoni PA; Masci E; Marchi R; Guslandi M; Ronchi G; Tittobello A
J Clin Gastroenterol; 1987 Jun; 9(3):298-302. PubMed ID: 3611683
[TBL] [Abstract][Full Text] [Related]
7. The gastric mucosa in gastric cancer patients in a low-incidence area.
Genta RM; Pusztaszeri M
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1085-93. PubMed ID: 16957515
[TBL] [Abstract][Full Text] [Related]
8. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
9. [Gastric mucosal lesions and their transition rates in high risk population of gastric cancer].
You WC
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):100-2. PubMed ID: 1879285
[TBL] [Abstract][Full Text] [Related]
10. Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study.
Rugge M; Baffa R; Farinati F; Di Mario F; Guido M; Valiante F; Ninfo V
Ital J Gastroenterol; 1991 Feb; 23(2):70-3. PubMed ID: 1747506
[TBL] [Abstract][Full Text] [Related]
11. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
12. Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
Lahner E; Corleto VD; D'Ambra G; Di Giulio E; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2008 Feb; 27(4):355-65. PubMed ID: 18047563
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer.
den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ
Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073
[TBL] [Abstract][Full Text] [Related]
14. [Gastroscopy in follow-up studies of patients with chronic atrophic gastritis and diagnosis of early gastric cancer].
Sokolov LK; Nikiforov PA; Vasil'ev ID; Gul'kevich KIu; Sklianskaia OA; Iarushnikov KIu
Klin Med (Mosk); 1990 Nov; 68(11):108-11. PubMed ID: 2283796
[TBL] [Abstract][Full Text] [Related]
15. [Non-specific chronic gastritis and gastric dysplasia, what is their clinical values?].
Martínez Alcalá F; Rivera Hueto F; Galera Davidson H; Martínez Pérez F
Rev Esp Enferm Apar Dig; 1989 Dec; 76(6 Pt 1):545-50. PubMed ID: 2623309
[TBL] [Abstract][Full Text] [Related]
16. [Risk findings of the gastric mucosa--a clinicopathologic discussion].
Heilmann KL; Lux G
Leber Magen Darm; 1985 Jan; 15(1):1-12. PubMed ID: 3974395
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up.
Di Giulio E; Lahner E; Micheletti A; Milione M; D'Ambra G; Bordi C; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2005 Mar; 21(5):567-74. PubMed ID: 15740540
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection.
Lahner E; Bordi C; Cattaruzza MS; Iannoni C; Milione M; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2005 Sep; 22(5):471-81. PubMed ID: 16128686
[TBL] [Abstract][Full Text] [Related]
19. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
[TBL] [Abstract][Full Text] [Related]
20. A topographic analysis of atrophic gastritis and stomach cancer risk. A clinicoepidemiological study in Poland.
Jedrychowski W; Popiela T; Steindorf K; Matyja A; Gryglewski A; Nowak K; Kieltyka A; Wahrendorf J; Becher H
Cent Eur J Public Health; 1997 Sep; 5(3):117-21. PubMed ID: 9386896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
